• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于非洲新冠病毒疾病(COVID-19)病例低发病率和低死亡率可能原因的最新情况。

Recent updates on the possible reasons for the low incidence and morbidity of COVID-19 cases in Africa.

作者信息

Tsinda Emmanuel Kagning, Mmbando Gideon Sadikiel

机构信息

Graduate School of Medicine, Tohoku University, Sendai, 980-8575 Japan.

Graduate School of Life Sciences, Tohoku University, Sendai, 980-8577 Japan.

出版信息

Bull Natl Res Cent. 2021;45(1):133. doi: 10.1186/s42269-021-00589-9. Epub 2021 Jul 23.

DOI:10.1186/s42269-021-00589-9
PMID:34335014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8300982/
Abstract

BACKGROUND

The COVID-19 respiratory illness caused by the SARS-CoV-2 has been a major cause of morbidity and mortality worldwide since the first reported case in Wuhan, China. A year has passed since pandemic began, and the reasons for different COVID-19 burden variation across continents keep puzzling the general public.

MAIN BODY OF THE ABSTRACT

Since the COVID-19 pandemic started, published research articles have addressed the epidemiological risk factors, host factors, susceptibility and immunity. To ascertain possible reasons for the different rates of COVID-19 infections between Africa and other continents, we summarized the up-to-date scientific literature to identify possible arguments in this regard. Available literature suggests that demographic, epidemiological, sociological, genetic and immunological factors contribute in the COVID-19 severity and the susceptibly to SARS-CoV-2.

SHORT CONCLUSION

This review summarizes existing data and discusses reasons for differential COVID-19 burden across continents. The arguments mentioned herein will be helpful to guide future experimental studies to test different hypotheses.

摘要

背景

自中国武汉首次报告病例以来,由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病呼吸道疾病一直是全球发病和死亡的主要原因。自疫情开始以来已过去一年,各大洲2019冠状病毒病负担差异的原因一直困扰着公众。

摘要正文

自2019冠状病毒病疫情开始以来,已发表的研究文章探讨了流行病学风险因素、宿主因素、易感性和免疫力。为了确定非洲与其他大洲之间2019冠状病毒病感染率不同的可能原因,我们总结了最新的科学文献,以找出这方面可能的论据。现有文献表明,人口统计学、流行病学、社会学、遗传学和免疫学因素会影响2019冠状病毒病的严重程度以及对SARS-CoV-2的易感性。

简短结论

本综述总结了现有数据,并讨论了各大洲2019冠状病毒病负担差异的原因。本文提及的论据将有助于指导未来的实验研究来检验不同的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/8300982/8350ab43b40a/42269_2021_589_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/8300982/8350ab43b40a/42269_2021_589_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/8300982/8350ab43b40a/42269_2021_589_Fig1_HTML.jpg

相似文献

1
Recent updates on the possible reasons for the low incidence and morbidity of COVID-19 cases in Africa.关于非洲新冠病毒疾病(COVID-19)病例低发病率和低死亡率可能原因的最新情况。
Bull Natl Res Cent. 2021;45(1):133. doi: 10.1186/s42269-021-00589-9. Epub 2021 Jul 23.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.新出现的冠状病毒:首例SARS、第二例MERS和第三例SARS-CoV-2:新型冠状病毒肺炎的流行病学新进展
Infez Med. 2020 Jun 1;28(suppl 1):6-17.
4
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.2019 冠状病毒病(COVID-19)大流行与妊娠。
Am J Obstet Gynecol. 2020 Jun;222(6):521-531. doi: 10.1016/j.ajog.2020.03.021. Epub 2020 Mar 23.
5
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions.当前 COVID-19 研究的范式:提出的治疗策略、最新趋势和未来方向。
Curr Med Chem. 2021;28(16):3173-3192. doi: 10.2174/0929867327666200711153829.
6
Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.COVID-19 病例的临床谱及其与 S.LDH 水平的相关性-来自拉贾斯坦邦东南部的观察性研究。
J Assoc Physicians India. 2021 Sep;69(9):11-12.
7
Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates.对 2019 年新型冠状病毒病(COVID-19)的深入了解:当前的认识、研究和治疗进展。
Recent Pat Biotechnol. 2022;16(1):35-63. doi: 10.2174/1872208315666210805152122.
8
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.中东和北非地区的 SARS-CoV-2 监测:纵向趋势分析。
J Med Internet Res. 2021 Jan 15;23(1):e25830. doi: 10.2196/25830.
9
The Young Age and Plant-Based Diet Hypothesis for Low SARS-CoV-2 Infection and COVID-19 Pandemic in Sub-Saharan Africa.撒哈拉以南非洲地区 SARS-CoV-2 感染率和 COVID-19 大流行率低的低龄和植物性饮食假说。
Plant Foods Hum Nutr. 2021 Sep;76(3):270-280. doi: 10.1007/s11130-021-00907-6. Epub 2021 Jun 24.
10
Zoonotic and reverse zoonotic transmission of severe acute respiratory syndrome coronavirus 2: a review and implications for Africa.严重急性呼吸综合征冠状病毒 2 的人畜共患和反向人畜共患传播:综述及其对非洲的影响。
Pan Afr Med J. 2021 Jan 14;38:39. doi: 10.11604/pamj.2021.38.39.24170. eCollection 2021.

引用本文的文献

1
COVID-19 inflammatory signature in a Mozambican cohort: unchanged red blood series and reduced levels of IL-6 and other proinflammatory cytokines.莫桑比克队列中的 COVID-19 炎症特征:红细胞系列不变,IL-6 和其他促炎细胞因子水平降低。
BMC Infect Dis. 2024 Nov 11;24(1):1279. doi: 10.1186/s12879-024-10132-6.
2
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools.关注边缘群体:利用最佳定性血清学评估工具评估拉丁裔和非裔社区中 COVID-19 的影响。
PLoS One. 2024 Jul 25;19(7):e0307568. doi: 10.1371/journal.pone.0307568. eCollection 2024.
3

本文引用的文献

1
COVID-19 transmission risk factors.COVID-19 传播风险因素。
Pathog Glob Health. 2022 May;116(3):146-177. doi: 10.1080/20477724.2021.1993676. Epub 2021 Dec 28.
2
COVID-19: Unpacking the low number of cases in Africa.新冠肺炎:剖析非洲确诊病例数较少的原因
Public Health Pract (Oxf). 2020 Nov;1:100038. doi: 10.1016/j.puhip.2020.100038. Epub 2020 Dec 22.
3
Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review.非洲 COVID-19 感染、疾病严重程度和相关死亡的风险因素:系统评价。
Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.
SARS-CoV-2 在乌干达和马拉维的一组孕妇及其婴儿中的血清流行病学研究。
PLoS One. 2024 Mar 1;19(3):e0290913. doi: 10.1371/journal.pone.0290913. eCollection 2024.
4
Impact of geographical, meteorological, demographic, and economic indicators on the trend of COVID-19: A global evidence from 202 affected countries.地理、气象、人口和经济指标对新冠疫情趋势的影响:来自202个受影响国家的全球证据
Heliyon. 2023 Aug 28;9(9):e19365. doi: 10.1016/j.heliyon.2023.e19365. eCollection 2023 Sep.
5
Newly arrived migrants did not represent an additional COVID-19 burden for Italy: data from the italian information flow.新抵达的移民并未给意大利带来额外的 COVID-19 负担:来自意大利信息流的数据。
Global Health. 2023 May 2;19(1):32. doi: 10.1186/s12992-023-00926-9.
6
Spread and seasonality of COVID-19 pandemic confirmed cases in sub-Saharan Africa: experience from Democratic Republic of Congo, Nigeria, Senegal, and Uganda.撒哈拉以南非洲地区 COVID-19 确诊病例的传播和季节性:来自刚果民主共和国、尼日利亚、塞内加尔和乌干达的经验。
BMC Infect Dis. 2023 Mar 29;23(1):187. doi: 10.1186/s12879-023-08168-1.
7
COVID-19 and its prevention in internally displaced person (IDP) camps in Somalia: impact on livelihood, food security and mental health.COVID-19 及其在索马里境内流离失所者营地中的预防:对生计、粮食安全和心理健康的影响。
BMC Public Health. 2022 Dec 22;22(1):2414. doi: 10.1186/s12889-022-14878-z.
8
SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020.马拉维基于对 5 个高负担地区社区和卫生工作者调查数据的 SARS-CoV-2 流行率,2020 年 10 月。
Emerg Infect Dis. 2022 Dec;28(13):S76-S84. doi: 10.3201/eid2813.212348.
9
Two Years into the COVID-19 Pandemic: Lessons Learned.新冠疫情两年:经验教训
ACS Infect Dis. 2022 Sep 9;8(9):1758-1814. doi: 10.1021/acsinfecdis.2c00204. Epub 2022 Aug 8.
10
The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: A Cross-Country Analysis.非洲 COVID-19 传播率和死亡率低的决定因素:跨国分析。
Front Public Health. 2021 Oct 21;9:751197. doi: 10.3389/fpubh.2021.751197. eCollection 2021.
BMJ Open. 2021 Feb 18;11(2):e044618. doi: 10.1136/bmjopen-2020-044618.
4
The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2.宿主细胞的组织血型抗原可能决定不同病毒(如 SARS-CoV-2)的结合。
Future Microbiol. 2021 Jan;16(2):107-118. doi: 10.2217/fmb-2020-0158. Epub 2021 Jan 18.
5
Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.TMPRSS2 的表达和共表达分析,COVID-19 的关键因素。
Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):451-455. doi: 10.1007/s10096-020-04089-y. Epub 2020 Nov 27.
6
Population risk factors for COVID-19 deaths in Nigeria at sub-national level.尼日利亚次国家层面新冠病毒疾病死亡的人群风险因素。
Pan Afr Med J. 2020 Aug 4;35(Suppl 2):131. doi: 10.11604/pamj.supp.2020.35.131.25258. eCollection 2020.
7
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.肯尼亚献血者中抗 SARS-CoV-2 IgG 抗体的血清流行率。
Science. 2021 Jan 1;371(6524):79-82. doi: 10.1126/science.abe1916. Epub 2020 Nov 11.
8
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses.BCG 疫苗接种不能预防 SARS-CoV-2,这一结论得到了流行病学分析的支持。
Sci Rep. 2020 Oct 27;10(1):18377. doi: 10.1038/s41598-020-75491-x.
9
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.巴西医护人员的卡介苗再接种以改善针对新冠病毒的先天免疫反应:一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):881. doi: 10.1186/s13063-020-04822-0.
10
Prevention of SARS-CoV-2 cell entry: insight from interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2.预防 SARS-CoV-2 细胞进入:从生物碱与刺突糖蛋白、人 ACE2 和 TMPRSS2 的相互作用中获得的见解。
J Biomol Struct Dyn. 2022 Mar;40(5):2121-2145. doi: 10.1080/07391102.2020.1835726. Epub 2020 Oct 22.